ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed Phase 3 COMPETE trial in an ...

One of the bigger talking points amongst media members and basketball fans on social media has been the shortcomings of the presentation of the 2025 NBA Finals on ABC, particularly when it comes ...

The pathology of tendinopathy has been described as degenerative or failed healing. Neither of these descriptions fully explains the heterogeneity of presentation. This review proposes, and provides ...

Forbes contributors publish independent expert analyses and insights. A former tech executive covering AI, XR and The Metaverse for Forbes.